A detailed history of Summitry LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Summitry LLC holds 394 shares of LLY stock, worth $343,950. This represents 0.02% of its overall portfolio holdings.

Number of Shares
394
Previous 546 27.84%
Holding current value
$343,950
Previous $483,000 37.06%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$727.2 - $932.06 $110,534 - $141,673
-152 Reduced 27.84%
394 $304,000
Q3 2024

Nov 07, 2024

BUY
$772.14 - $960.02 $196,895 - $244,805
255 Added 87.63%
546 $483,000
Q2 2024

Aug 09, 2024

SELL
$724.87 - $909.04 $36,243 - $45,452
-50 Reduced 14.66%
291 $263,000
Q1 2024

May 06, 2024

BUY
$592.2 - $792.28 $201,940 - $270,167
341 New
341 $265,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $829B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Summitry LLC Portfolio

Follow Summitry LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summitry LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summitry LLC with notifications on news.